Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-07-06 | 2021-07-01 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $191.64 | -5,000 | 396.6K | -1% | -$958.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-01 | S | D | 700 | $191.97 | 398,016 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $191.46 to $192.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-07-01 | S | D | 700 | $193.51 | 397,316 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $193.02 to $193.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-07-01 | S | D | 500 | $194.29 | 396,816 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $194.03 to $194.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-07-01 | S | D | 1,300 | $190.87 | 398,716 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $190.40 to $191.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-07-01 | S | D | 1,600 | $189.94 | 400,016 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $189.385 to $190.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-07-01 | S | D | 200 | $196.00 | 396,616 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $195.82 to $196.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |